Not sure of pharma products authenticity See its digital passport | Volga, Technology & innovation MarchmontNews.com

Volga | Technology & innovation | Retail, FMCG

Not sure of pharma products’ authenticity? See its digital passport

11 Sep '20
Two Russian companies, ANO Airalab Rus and Innocolloid, Inc., have been jointly working on what they refer to as “digital passport” for their new anti-viral blocker called Blokator.

The word came earlier this year from Zhigulevskaya Dolina, a large technopark and business incubator in Samara Oblast, in Russia’s Lower Volga region, which hosts ANO Airalab Rus as one of its numerous resident companies. Airalab’s partner in the effort, Innocolloid, is the co-founder of ITMO, one of the newest and most innovative universities in St. Petersburg.

The Blokator reportedly demonstrates disinfectant properties and is designed to thwart viral and microbial activity. Tests are said to have proved its efficacy in inhibiting human respiratory viruses—but the solution is not a drug in a strict therapeutic sense of the word. The Russian solution is meant to compete with Japanese anti-viral blockers that currently dominate the blockers market.